Odyssean »

Adaptive Biotechnologies Cor shares owned by Odyssean

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 68k 21.45

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
D. E. Shaw & Co
Westfield Capital Management Company
Wellington Management Company
Geode Capital Management
Lord, Abbett & Co
State Street Corporation
Invesco
Ameriprise Financial
Goldman Sachs Group
Bnp Paribas Investment Partners
Driehaus Capital Management

View all funds holding Adaptive Biotechnologies Cor